Pierre Leduc

Biomerge Industries Ltd. is a Canadian medical device company and leader in fluorescence endoscopy for improved cancer detection. The Company’s first-generation product, Xillix LIFE-Lung™ received Pre-Market Approval (PMA) from the U.S. FDA in 1996. Xillix’s latest device, Onco-LIFE™, incorporates fluorescence and white-light endoscopy in a single device that has been developed for the detection and localization of lung and gastrointestinal (GI) cancers.

VSM MedTech Ltd. manufactured blood pressure and heart rate monitors. It developed and marketed medical devices for the diagnosis and treatment of neurological disorders and cardiovascular diseases. The company was founded on October 19, 1995 and was headquartered in Coquitlam, Canada.

Venturi Ventures, Inc. engages in the development and marketing of its advanced verification of integration dose technology. The company was founded on December 3, 1980 and is headquartered in North Vancouver, Canada.

NOVX Systems, Inc. develops drug screening solutions. Its products include PatientVu, PatientVu Pain and UDS Tests and Dips. The company was founded by Tino Alavie in March 2001 and is headquartered in Richmond Hill, Canada.

Neurostream Technologies focuses on the development and commercialization of technologies and products that address unmet medical needs of patients suffering from neurological, neuromuscular or movement disorders. Neurostream Technologies is part of the Otto Bock Group, a global leader in orthotics-prosthetics.

Baxter World Trade Corp. is a manufacturer and distributor of health care products for hemophilia, immune disorders, cancer, infectious and kidney diseases treatment. The company was incorporated in 1979 and is based in Deerfield, Illinois.

Baxter Corp. supplies health care and laboratory products. Its products are used for treating cancer, hemophilia, immune deficiencies, kidney disease, and trauma. The company is headquartered in Mississauga, Canada